FL-802

N/A

Report date: 2026/05/14 20:00:28

Base Information

Drug NameFL-802

Drug Alias NameN/A

ClassificationRadiation-emitting products > Radioactive therapeutic agentRadiation-emitting products > Radionuclide Drug ConjugatesBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody fragment > Single-domain antibody (Nanobody) +[4]

Mechanisms of ActionAnti-CD276

TargetsCD276 antigen

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesFull Life Technologies Ltd

China Registration ClassN/A

Develop Information

Active CompaniesFull Life Technologies Ltd

Inactive CompaniesN/A

Active IndicationsNeoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A